# Risk of CV Events With EFV vs. EFV-free Regimens

> **NCT02426866** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 29612 (actual)

## Conditions studied

- HIV/AIDS

## Interventions

- **DRUG:** Efavirenz

## Key facts

- **NCT ID:** NCT02426866
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 29612 (ACTUAL)
- **Last updated:** 2015-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02426866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02426866, "Risk of CV Events With EFV vs. EFV-free Regimens". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02426866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*